With low doses, Zhou et al. showed that carboplatin induced DNA damage in the H3122 lung cancer cell line, which activated both canonical STING-IRF3 and non-canonical STING-NFκB signaling [117]. This evidence concerns the gene STING1 and lung carcinoma.